Press releases | November 6, 2017
Inmedix immuno-autonomics strategies projected to save payers billions
Immuno-autonomics treatment may affect the way patients, rheumatologists, the pharmaceutical industry and especially payers view treatment strategies in rheumatoid arthritis (RA).
Click below to read the full press release.